Champaign, IL, United States of America

Scott E Denmark

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2005-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Scott E Denmark: Innovator in Pharmaceutical Chemistry

Introduction

Scott E Denmark is a prominent inventor based in Champaign, IL (US), known for his significant contributions to pharmaceutical chemistry. With a total of seven patents to his name, Denmark has made remarkable advancements in the field, particularly in the development of novel compounds with therapeutic applications.

Latest Patents

Among his latest patents, Denmark has developed spirobicyclic analogues, which are innovative compounds useful as PRMT5 inhibitors. These compounds are detailed in his patent, which outlines their potential as active ingredients in pharmaceutical compositions. Additionally, he has contributed to non-invasive methods for determining the gender of an embryo during in vitro embryo culture, showcasing his versatility in research applications.

Career Highlights

Denmark has had a distinguished career, working with esteemed institutions such as the University of Illinois and Janssen Pharmaceutica NV. His work has not only advanced scientific knowledge but has also paved the way for new therapeutic strategies in medicine.

Collaborations

Throughout his career, Denmark has collaborated with notable colleagues, including Jonas Verhoeven and Guido Alfons F Verniest. These partnerships have enriched his research and contributed to the success of his innovative projects.

Conclusion

Scott E Denmark exemplifies the spirit of innovation in pharmaceutical chemistry through his patents and collaborative efforts. His work continues to impact the field significantly, making him a noteworthy figure in the realm of scientific invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…